UB17:LSE:LSE-UBS MSCI EMU Value UCITS EUR Adis (GBX)

ETF | Others |

Last Closing

USD 4377.75

Change

-4.25 (-0.10)%

Market Cap

N/A

Volume

488.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-12 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

+6.50 (+3.14%)

USD 1,607.29B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.17 (-1.15%)

USD 640.06B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.12 (-0.65%)

USD 640.06B
0R1I:LSE NVIDIA Corp.

+7.95 (+6.53%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
PRJU:LSE Amundi Index Solutions - Amund..

-0.23 (-0.72%)

USD 269.13B
0QZK:LSE Coca-Cola Co.

-0.30 (-0.43%)

USD 266.08B
0QZO:LSE 0QZO

+1.10 (+1.00%)

USD 258.54B
0QZ3:LSE Qualcomm Inc.

-1.50 (-0.98%)

USD 202.26B
0R24:LSE Intel Corp.

+0.71 (+3.22%)

USD 196.14B

ETFs Containing UB17:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 19.13% 88% B+ 85% B
Dividend Return 0.01% 22% F 14% F
Total Return 19.14% 87% B+ 85% B
Trailing 12 Months  
Capital Gain 9.03% 66% D+ 67% D+
Dividend Return 0.04% 29% F 25% F
Total Return 9.07% 64% D 65% D
Trailing 5 Years  
Capital Gain 80.23% 69% C- 74% C
Dividend Return 0.24% 32% F 43% F
Total Return 80.47% 66% D+ 72% C
Average Annual (5 Year Horizon)  
Capital Gain 7.69% 58% F 62% D
Dividend Return 7.70% 57% F 62% D
Total Return 0.01% 21% F 14% F
Risk Return Profile  
Volatility (Standard Deviation) 10.82% 58% F 76% C+
Risk Adjusted Return 71.13% 71% C- 82% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.